Literature DB >> 20874700

The urokinase receptor in the central nervous system.

Marco Archinti1, Mishan Britto, Gabriele Eden, Federico Furlan, Ronan Murphy, Bernard Degryse.   

Abstract

The urokinase receptor (uPAR) is a multifunctional glycosylphosphatidylinositol-anchored protein that regulates important processes such as gene expression, cell proliferation, adhesion, migration, invasion, and metastasis. uPAR is an essential component of the plasminogen activation cascade, a protease receptor that binds the urokinase-type plasminogen activator. uPAR is also an adhesion-modulating receptor, and a signalling receptor transmitting signals to the cell through lateral interactions with a wide array of membrane receptors. Altogether, the external ligands and membrane-bound partners of uPAR constitute a rich uPAR interactome. Recently, a new ligand of uPAR has been identified as the SRPX2 protein which is essential in language and cognitive development. SRPX2 is the second identified gene involved in language disorders. However, previous studies revealed cognitive disorders and defects in the development of the GABAergic interneurons in uPAR null mice. In addition, the expression of uPAR correlates with important human diseases such as epilepsy, autism, multiple sclerosis, Alzheimer's, AIDS dementia, cerebral malaria, and brain tumours. Therefore, uPAR has unexpectedly become a significant receptor in the central nervous system and made a few steps into philosophy. Language is indeed intimately linked to human culture. This in-depth review presents the structure and the sequences of uPAR that are essential for drug design and the generation of new inhibitors. In addition, we summarize all the inhibitors of uPAR that have been created so far. Finally, we discuss the functions of uPAR in the development, functioning, and pathology of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20874700     DOI: 10.2174/187152711794480393

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  10 in total

1.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

2.  Urokinase-type plasminogen activator (uPA) regulates the expression and function of growth-associated protein 43 (GAP-43) in the synapse.

Authors:  Paola Merino; Ariel Diaz; Enrique R Torre; Manuel Yepes
Journal:  J Biol Chem       Date:  2019-12-09       Impact factor: 5.157

3.  Urokinase-type plasminogen activator receptor modulates epileptogenesis in mouse model of temporal lobe epilepsy.

Authors:  Xavier Ekolle Ndode-Ekane; Asla Pitkänen
Journal:  Mol Neurobiol       Date:  2012-12-21       Impact factor: 5.590

4.  Genetic association of urokinase-type plasminogen activator gene rs2227564 site polymorphism with sporadic Alzheimer's disease in the Han Chinese population.

Authors:  Xuelian Ji; Longfei Jia; Jianping Jia; Li Qi
Journal:  Neural Regen Res       Date:  2012-10-25       Impact factor: 5.135

5.  Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion.

Authors:  Mingyan Lin; Erika Pedrosa; Anastasia Hrabovsky; Jian Chen; Benjamin R Puliafito; Stephanie R Gilbert; Deyou Zheng; Herbert M Lachman
Journal:  BMC Syst Biol       Date:  2016-11-15

6.  Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR.

Authors:  Bernard Degryse; Mishan Britto; Chun Xu Shan; Robert G Wallace; Keith D Rochfort; Philip M Cummins; Gerardene Meade; Ronan P Murphy
Journal:  Data Brief       Date:  2017-10-16

7.  Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors.

Authors:  John H Rossmeisl; Kelli Hall-Manning; John L Robertson; Jamie N King; Rafael V Davalos; Waldemar Debinski; Subbiah Elankumaran
Journal:  Onco Targets Ther       Date:  2017-04-12       Impact factor: 4.147

Review 8.  Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.

Authors:  V M Baart; R D Houvast; L F de Geus-Oei; P H A Quax; P J K Kuppen; A L Vahrmeijer; C F M Sier
Journal:  EJNMMI Res       Date:  2020-07-28       Impact factor: 3.138

9.  Laser Capture Microdissection-Based RNA Microsequencing Reveals Optic Nerve Crush-Related Early mRNA Alterations in Retinal Ganglion Cell Layer.

Authors:  Dongyan Pan; Mengqiao Xu; Xin Chang; Mao Xia; Yibin Fang; Yinghua Fu; Wei Shen; Yue Wang; Xiaodong Sun
Journal:  Transl Vis Sci Technol       Date:  2020-10-27       Impact factor: 3.283

10.  HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.

Authors:  Tamara Mirzapoiazova; Nurbek Mambetsariev; Frances E Lennon; Bolot Mambetsariev; Joshua E Berlind; Ravi Salgia; Patrick A Singleton
Journal:  Front Oncol       Date:  2015-07-21       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.